2020
DOI: 10.1007/s11164-020-04146-3
|View full text |Cite
|
Sign up to set email alerts
|

Structural characterization, thermal, DFT, cytotoxicity, and antimetastatic properties of cocaine complexes with La(III), Er(III), and Yb(III)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 18 publications
(7 citation statements)
references
References 61 publications
0
7
0
Order By: Relevance
“…In addition, H 2 L 2 ligand acted as mono negative bidentate chelating agent, coordinated to the metal ions via a nitrogen atom and deprotonated phenolic oxygen atom of the H 2 L 2 Schiff base ligand. [ 2,22,26 ]…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…In addition, H 2 L 2 ligand acted as mono negative bidentate chelating agent, coordinated to the metal ions via a nitrogen atom and deprotonated phenolic oxygen atom of the H 2 L 2 Schiff base ligand. [ 2,22,26 ]…”
Section: Resultsmentioning
confidence: 99%
“…In addition, H 2 L 2 ligand acted as mono negative bidentate chelating agent, coordinated to the metal ions via a nitrogen atom and deprotonated phenolic oxygen atom of the H 2 L 2 Schiff base ligand. [2,22,26] 3.4 | 1 H NMR spectra 1 H nuclear magnetic resonance (NMR) spectral data (δ ppm) of the free ligands were previously reported. [22,26] By comparing the spectral data of the free H ).…”
Section: Infrared Spectramentioning
confidence: 99%
See 1 more Smart Citation
“…[ 31–36 ] In 1909, cocaine (COC) (Figure 1a), a natural product containing azabicyclo[3.2.1]octane that is extracted from the leaves of the coca bush ( Erythroxylum coca ) plant, [ 37 ] was reported as an anticancer drug by Gilchrist. [ 38 ] Research in this regard has led to the recent development of different binary [ 39,40 ] and heteroleptic [ 41 ] metal complexes of COC exhibiting anticancer activity.…”
Section: Introductionmentioning
confidence: 99%
“…Cn was first reported as a cancer treatment by Gilchrist in 1909 [17]. Additionally, different binary transition metal complexes [18] and heteroleptic lanthanide-metal complexes [19] of Cn have been recently investigated for their anticancer activity.…”
Section: Introductionmentioning
confidence: 99%